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ABSTRACT
Physiological and pathophysiological stress attenu-
ates global translation via phosphorylation of eIF2a.
This in turn leads to the reprogramming of gene
expression that is required for adaptive stress re-
sponse. One class of cellular messenger RNAs
whose translation was reported to be insensitive to
eIF2a phosphorylation-mediated repression of trans-
lation is that harboring an Internal Ribosome Entry
Site (IRES). IRES-mediated translation of several
apoptosis-regulating genes increases in response
to hypoxia, serum deprivation or gamma irradiation
and promotes tumor cell survival and
chemoresistance. However, the molecular mechan-
ism that allows IRES-mediated translation to
continue in an eIF2a-independent manner is not
known. Here we have used the X-chromosome
linked Inhibitor of Apoptosis, XIAP, IRES to
address this question. Using toeprinting assay,
western blot analysis and polysomal profiling we
show that the XIAP IRES supports cap-independent
translation when eIF2a is phosphorylated both
in vitro and in vivo. During normal growth condition
eIF2a-dependent translation on the IRES is
preferred. However, IRES-mediated translation
switches to eIF5B-dependent mode when eIF2a is
phosphorylated as a consequence of cellular stress.
INTRODUCTION
A sizeable proportion of cellular messenger RNAs
(mRNAs) has been shown to be translated by a
cap-independent mechanism using an Internal Ribosome
Entry Site (IRES) element (1–3). Many mRNAs that
contain IRES encode proteins that play important roles
in cell growth, proliferation, differentiation and the
regulation of apoptosis. The IRES mechanism is utilized
preferentially during conditions when normal
cap-dependent translation initiation is compromised and
in fact represents a critical survival ‘switch’ during onco-
genesis (3,4). Translational control by internal initiation
thus represents a novel and unique regulatory mechanism
that is critical for cell survival; however, the mechanistic
understanding of cellular IRES-mediated translation is
missing.
Initiation of translation in eukaryotes is a complex and
highly regulated process. Brieﬂy, eukaryotic mRNAs
contain a m
7G cap structure at the 50-end that is essential
for their translation. Cap-dependent initiation requires
interaction of initiation factor eIF4E (the cap-binding
protein) and its partners eIF4A and eIF4G with the
50-end of the mRNA, which is then followed by recruit-
ment of ribosomal subunits, recognition of the AUG start
codon and commencement of polypeptide chain elong-
ation (1,5). In contrast, IRES are thought to recruit 40S
ribosomal subunit directly to the vicinity of the initiation
codon, thereby bypassing the requirement for the 50
cap-structure and eIF4E binding. With the exception of
some viral RNAs, there is no evidence to suggest that the
steps following 40S recruitment to the mRNA differ
between the cap- and IRES-dependent translation initi-
ation mechanisms of eukaryotic mRNAs.
Cells respond to physiological and pathophysiological
stress by phosphorylation of a subunit of eIF2 which
results in an attenuation of global protein synthesis.
eIF2 is required for the formation of ternary complex and
delivery of Met-RNAi
Met into the P-site of the ribosome to
initiate protein synthesis (6). Phosphorylation of eIF2a
leads to reduced availability of ternary complex, and a
concomitant decrease in global translation rates (6).
However, translation of some mRNAs (such as ATF4
and GCN2) continues (or is even enhanced) under condi-
tions that cause eIF2a phosphorylation since their trans-
lation is controlled by upstream open reading frames, a
setting in which low levels of ternary complex promote
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Continuous translation of several IRES-containing
mRNAs during conditions of phosphorylated eIF2a and
reduced ternary complex availability has also been
reported. For example, translation of vascular endothelial
growth factor (VEGF) was substantially increased during
tumor hypoxia (4), while the IRES-mediated translation
of X-chromosome linked Inhibitor of Apoptosis (XIAP)
sustained during ER stress (7), or was increased in
response to serum starvation, low-dose gamma irradiation
or glucose deﬁciency (8–11). It is not clear, however, how
IRES-mediated translation of cellular mRNAs proceeds
under these conditions, and what is the precise molecular
mechanism that allows cellular IRES to function in an
eIF2a-independent manner. We have used the XIAP
IRES element to address this question.
XIAP is a prototype member of the Inhibitor of
Apoptosis (IAP) protein family, which binds to and in-
hibits key caspases involved both in the initiation and exe-
cution steps of apoptosis (12). There is now overwhelming
evidence for a role for the IAP genes, and XIAP in par-
ticular, in cancer (13). Targeting of XIAP is a promising
therapeutic opportunity in the treatment of cancer and is
currently in clinical trials (14–17). XIAP is encoded by two
distinct mRNAs that differ in their 50-UTRs; the major,
shorter 50-UTR promotes a basal level of XIAP expression
under normal growth conditions, while the less abun-
dant, longer 50-UTR contains an IRES element and
supports cap-independent translation during stress (11).
Importantly, the IRES-mediated upregulation of XIAP
in response to irradiation, IL-6 treatment or cellular trans-
formation enhances cell survival, conﬁrming that IRES-
dependent translation of XIAP is critically involved in
mediating tumor cell survival (8,9,18,19). In this report
we have extensively characterized the XIAP IRES by
toeprinting assay for its function in vitro. We demonstrate
that XIAP IRES is able to form translation-competent
initiation complexes in a cap-independent manner, both
in untreated and poly I:C treated rabbit reticulocyte
lysate (RRL), which induces eIF2a phosphorylation.
Furthermore, we describe the mechanism by which trans-
lation initiation proceeds on cellular IRES when eIF2a is
phosphorylated. We identify an eIF5B-dependent switch
that promotes IRES-mediated translation during condi-
tions of pathophysiological stress both in vitro and
in vivo. Our data demonstrate that the eIF2a-dependent
pathway is utilized for IRES-dependent translation initi-
ation during normal growth conditions, whereas cellular
stresses that inactivate eIF2a by phosphorylation cause
IRES-dependent translation to switch to an eIF5B-
dependent mode.
MATERIALS AND METHODS
Constructs, cell culture and transfection
The hepatitis C virus (HCV) IRES construct described pre-
viously (20,21), which contains both streptotag aptamer
and a unique toeprint primer-binding site, was obtained
as a gift from Dr Peter Lukavsky. The XIAP IRES con-
struct was generated by replacing the HCV IRES with the
XIAPIRESsequence(171nt)alongwith38ntofcodingre-
gion and T7 promoter sequences. Similarly, the human
b-globin 50-UTR (50nt along with 248nt coding sequence;
derived from clone 6663141, Open Biosystems) was used to
replace the HCV IRES. The PPT mutant and SC mutants
were created by site-directed mutagenesis of the XIAP IRES
construct using primers listed in Supplementary Table S1. All
plasmids were veriﬁed by restriction digest and sequencing.
HEK293T cells were maintained in standard condi-
tions in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
and transfection of small interfering RNAs (siRNAs) was
performed using Lipofectamine RNAimax (Invitrogen).
Brieﬂy, cells were seeded at a density of 2.5 10
5 cells/
well in 6-well plates and simultaneously transfected with
20nM of Stealth RNAi
TM siRNAs targeting eIF5B or
non-targeting siRNA control (Invitrogen). Seventy-two
hours post-transfection, eIF2a phosphorylation was
induced by poly I:C transfection (25mg/ml) using
Lipofectamine 2000 (Invitrogen). Eighteen hours after
poly I:C transfection cells were harvested in RIPA buffer
[50 mM Tris–HCl (pH 7.4), 150mM NaCl, 1mM EDTA,
1% (vol/vol) NP40, 0.05% (wt/vol) SDS, 0.5% (wt/vol)
Deoxycholic acid] for western blot analysis, or in RNA
lysis buffer [15 mM Tris (pH 7.4), 15mM MgCl2,
300mM NaCl, 1% (vol/vol) Triton-X100, 100U/ml
RNAsin and 0.1mg/ml Cycloheximide (CHX)] for
polysome proﬁling.
In vitro transcription
DNA templates used for the synthesis of RNAs for the
toeprinting assays and streptomycin afﬁnity chromatog-
raphy were ampliﬁed by polymerase chain reaction (PCR)
from the above-mentioned constructs. The 50 primers
incorporated the T7 promoter sequence to allow for
RNA transcription; the reverse primer included strepto-
tag aptamer sequence and 51T residues (Supplementary
Table S1) which were added to the end of the PCR
products to provide poly-A tail for the transcribed
RNA. In vitro transcription was performed using the
Megashortscript and mMessage mMachine kit (Ambion)
was used to generate capped versions of RNA. The
newly-synthesized RNA was puriﬁed by size exclusion
chromatography (22) or ethanol precipitation.
Toeprinting assay
Toeprinting was performed as described by Locker and
Lukavsky (21), with some modiﬁcations. Brieﬂy, the RRL
(GreenHectares)wastreatedwithRNAsein(Promega)and
Guanosine 50-[b,g-imido]triphosphate (GMP-PNP) for
5min at 30 C. RRL was treated ﬁrst with poly I:C &
adenosine triphosphate (ATP) at 37 C for 20min if
the toeprinting assay was performed in the presence of
poly I:C. Subsequently, RNA, ATP and guanosine
triphosphatecDNA (GTP) were added, as indicated, and
the reactions were incubated at 30 C for further 5min.
The reaction volume was brought to 40ml by the addition
of toeprinting buffer [20 mM Tris–HCl (pH 7.6), 100mM
KOAc, 2.5mM MG(OAc)2, 5% (wt/vol) sucrose, 2mM
DTT and 0.5mM spermidine] and incubated at 30 C
for 3min. Subsequently, 5pmol of toeprinting primer
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IRDye
TM800)wasaddedandreactionwasincubatedonice
for 10min. A quantity of 1mM dNTPs, 5mM Mg(OAc)2
and 1ml of avian myeloblastosis virus reverse transcriptase
(Promega) were added to the reaction and the ﬁnal volume
was brought to 50ml by toeprinting buffer. Primer exten-
sion was allowed to occur for 45min at 30 C. The cDNA
products were puriﬁed by phenol:chloroform extraction
and analyzed on a standard 6% sequencing gel using a
model 4200 IR2 sequence analyzer (LI-COR, Lincoln,
Nebraska, USA). The concentrations of the toeprinting
assay components are as follows unless otherwise speciﬁed:
RRL, 15ml; GMP-PNP, 1.7mM; ATP, 1.82mM; GTP,
1.8mM; RNA, 800ng; poly I:C, 150ng/ml.
Western blot analysis
Cells were lysed in RIPA buffer for 30min at 4 C,
followed by centrifugation at 13000rpm to remove debris.
Equal amounts of protein were resolved by 10% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–
PAGE), transferred to nitrocellulose membranes and
probed with antibodies against GST-XIAP (23), b-actin
(Abcam), phospho-eIF2a (Abcam), eIF2a (Abcam) and
eIF5B (Protein Technology). Membranes were then in-
cubated with species-speciﬁc horseradish peroxidase-
conjugated secondary antibody (Cell Signaling) followed
by detection with ECL substrate (Pierce), and quantiﬁed
using Odyssey densitometry software (LI-COR).
Polysome proﬁling and quantitative reverse transcription–
PCR
HEK293T cells from two 6-well plates per condition were
lysed in RNA lysis buffer and polysomal proﬁling was
performed as described (11). Gradients were fractionated
using ISCO gradient fraction collector machine. The frac-
tions (1ml) were spiked with 100ng of an in vitro trans-
cribed chloramphenicol acetyltransferase (CAT) RNA, to
ensure technical consistency in RNA isolation. RNA was
isolated as described (11) and cDNA was generated from
equal volumes of RNA using the qScript
TM reverse tran-
scription kit (Quanta Biosciences). Quantitative PCR
was performed on a Realplex
2 real-time thermocycler
with PerfeCTa
TM SYBR Green FastMix
TM (Quanta
Biosciences) using primers speciﬁc to IRES containing
(longer UTR) and non-IRES (shorter UTR) mRNA of
XIAP, CAT or b-actin (Supplementary Table S2).
RNA-streptomycin afﬁnity chromatography
Untreated RRL of 4ml (Green Hectares) was incubated
with 150ng/ml poly I:C, 1mM ATP, 10ml ribonuclease
inhibitor (Promega) and 0.1mg/ml CHX at 37 C for
20min. Binding buffer of 12ml [20mM Tris (pH 7.6),
10mM MgCl2, 120mM KCl, 8% sucrose, 2mM dithio-
threitol] containing EDTA-free protease inhibitor cocktail
(Roche) and 1mM puromycin was mixed with RRL and
the reaction was incubated at 37 C for 10min. An in vitro
transcribed, uncapped strepto-tagged XIAP IRES RNA,
1mM GTP and 40S and 60S ribosomal subunits puriﬁed
from HeLa cells were added to the RRL and further
incubated for 10min at 37 C to form the 80S initiation
complex. RNA-dihydrostreptomycin afﬁnity chromatog-
raphy was performed as described (20,21) and the isolated
initiation complex was analyzed by Tris/Borate/EDTA
(TBE) agarose gel electrophoresis and a toeprinting
assay. The negative control experiment was performed in
the same manner using 1ml RRL and 3ml binding buffer
but XIAP IRES RNA was omitted.
RESULTS
In vitro characterization of the XIAP IRES initiation
complex
Stress-induced translation of XIAP mRNA is driven by
an IRES element (24); however, the mechanism of XIAP
IRES function is not known. The ability of the XIAP
IRES to nucleate the formation of initiation complex
was determined using toeprinting assay on an in vitro
transcribed uncapped XIAP IRES RNA (Fig. 1A). After
XIAP IRES initiation complexes were allowed to form in
RRL, reverse transcription of the mRNA-ribosome
complex typically yielded toeprints +17 to +19nt down-
stream of AUG (Fig. 1B, lanes 1–6), which is a hallmark
of ribosome recruitment to the AUG and stable ribo-
some–RNA complex formation (25–27). The ability of
XIAP IRES to recruit ribosomes was impaired in the ab-
sence of a poly A tail (Figure 1B, lanes 7 and 8) which is in
accordance with previously published reports (28). XIAP
IRES initiation complexes could be further differentiated
depending on the distribution of ﬂuorescence intensities
between +17 to +19nt (Fig. 1C) as described previously
(27). The type of initiation complex observed was depend-
ent on the type of guanine nucleotide treatment. When
RRL was pretreated with GMP-PNP or GMP-PNP and
ATP, a 48S initiation complex was formed (characterized
by toeprint distribution+17 +18 >+19; Figure 1C, lanes
2 and 5). In contrast, 80S complex was observed in GTP,
ATP or GTP+ATP treated, or untreated RRL
(characterized by toeprint distribution +17<+18> +19;
Figure 1C, lanes 1, 3, 4 and 6). Importantly, reverse tran-
scription of XIAP IRES RNA in the absence of RRL,
GMP-PNP, GTP or ATP did not yield any toeprints in
the +17 to +19 range (Supplementary Figure S1A),
strongly indicating that the+17 to+19 toeprints are not
due to hindrance by the structure of the mRNA during
reverse transcription, but rather are the result of speciﬁc
ribosome recruitment to the XIAP IRES. We will refer to
these toeprints as 40S leading edge toeprints.
To further authenticate the formation of 40S leading
edge toeprints on the XIAP IRES, additional control ex-
periments were performed. First, the initiation codon
AUG was mutated to AAC (highlighted by a circle in
Figure 2A; referred to as Start Codon, SC, mutant). The
40S leading edge toeprints were not observed with the SC
mutant (Figure 2B, lane 4). These data conﬁrm that XIAP
IRES initiation complexes are formed on the authentic
initiation AUG codon. Second, the substitution of UU
to AA in the polypyrimidine tract (PPT) of XIAP IRES
(highlighted by a rectangle in Figure 2A) was shown to
result in a complete loss of XIAP IRES activity in the
bicistronic reporter assay (24). Toeprinting assay was
Nucleic AcidsResearch, 2012, Vol.40,No. 2 543therefore performed using the same PPT mutant. The
absence of 40S leading edge toeprints indicates the inabil-
ity of the XIAP IRES PPT mutant to form an initiation
complex (Fig. 2B, lane 2). Strikingly, the PPT mutant
was able to form an initiation complex once a m
7G cap
was added to the 50-end of the in vitro transcribed
RNA (Figure 2B, lane 3). Finally, the 48S initiation
complex was detected only on m
7G-capped human
b-globin RNA, and not in the absence of the cap
(Supplementary Figure S1B). Together, these data
conﬁrm that the in vitro conditions established in the
RRL system do not allow for random recruitment of the
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Figure 1. Initiation complex formation on uncapped XIAP IRES RNA. (A) Schematic diagram of the DNA construct of the streptomycin
aptamer-tagged XIAP IRES RNA used for analysis of initiation complexes by toeprinting and afﬁnity puriﬁcation. (B) XIAP IRES initiation
complexes were formed on the in vitro transcribed RNA with or without poly-A tail in RRL pre-treated with GMP-PNP or GTP and/or ATP.
Subsequently, initiation complexes were analyzed by toeprinting. (C) A magniﬁed portion of the toeprinting gel showing toeprints from+17 to+19
downstream of the AUG with the distribution of ﬂuorescence intensities indicated. XIAP IRES initiation complexes 48S, 80S or 48S+80S were
determined as described by Shirokikh et al. (27).
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7G
cap or a functional IRES element are stringent require-
ments for ribosome recruitment and initiation complex
formation.
In addition to the +17 to+19 toeprints we also
observed toeprints at+8 to+11,+29 to +30 and+35 to
+39nt downstream of the AUG in XIAP IRES RNA. It
was suggested previously that such toeprints could repre-
sent ‘ribosomal jumps’ (29). However, the addition of
cycloheximide (which freezes the ribosome) to RRL did
not eliminate these toeprints (Supplementary Figure S1C,
lane 4), thus ruling them out as ‘ribosomal jumps’.
Furthermore, these additional toeprints were absent
from the PPT or SC mutants of XIAP IRES RNA,
which are unable to recruit the ribosome (Figure 2B
lanes 2 and 4). These observations suggest that ribosome
recruitment to the AUG induces overall structural re-
arrangement of XIAP IRES RNA, which results in add-
itional toeprints at +8 to +11, +29 to +30 and +35 to
+39nt downstream of AUG.
Formation of the XIAP IRES initiation complex is not
dependent on eIF2a
Poly (I)-poly(C) (poly I:C) treatment of RRL activates
double stranded RNA (dsRNA)-dependent protein
kinase (PKR), which leads to phosphorylation of eIF2a
and subsequent attenuation of cap-dependent protein
translation (30). Treatment of RRL with poly I:C
(150ng/ml) for 5 to 8min results in a complete shut-off
of protein synthesis (30,31).We wished to use this system
to study XIAP IRES initiation under conditions of
cellular stress. Sustained phosphorylation of eIF2a was
observed in RRL following poly I:C treatment (Figure
3A), which resulted in the inhibition of translation as
indicated by the inability of the capped XIAP IRES
PPT mutant to form the 40S leading edge toeprint
(Figure 3C, lane 2). Strikingly, the uncapped wt XIAP
IRES RNA was able to form an initiation complex in
the poly I:C-treated RRL (Figure 3B, lanes 2 and 3),
and in fact the ﬂuorescence intensity of the 40S leading
edge toeprints was enhanced by poly I:C treatment
(Figure 3B, lanes 2 and 3). These data indicate that
XIAP IRES-dependent translation initiation proceeds in
poly I:C treated RRL, whereas cap-dependent translation
initiation is inhibited. Reverse transcription of XIAP
IRES RNA in the absence of RRL, GMP-PNP, GTP
and ATP, but in the presence of poly I:C, did not show
any toeprints +17 to +19nt downstream of AUG
(Supplementary Figure S2). This result conﬁrms that
these toeprints are not due to XIAP IRES RNA structure
changes that may be potentially caused by poly I:C treat-
ment, which could hinder the reverse transcriptase.
We further wished to conﬁrm the nature of the observed
40S leading edge toeprints, and therefore used a strepto-
mycin–RNA afﬁnity chromatography approach (20,21) to
isolate and characterize initiation complex formed on the
XIAP IRES RNA. An in vitro transcribed uncapped
strepto-tagged XIAP IRES RNA was incubated with
poly I:C and cycloheximide-treated RRL. In order to
achieve higher yield of XIAP IRES RNA ribosome
complex, the nuclease untreated RRL was supplemented
with puriﬁed 40S and 60S from HeLa cells. Following
initiation complex formation, strepto-tagged XIAP IRES
RNA was captured on dihydrostreptomycin resin, washed
AUG
17 - 19 NT
from AUG
Full Length
- - - + XIAP IRES RNA
- - + - PPT mutant
T4 C G3 2 1 A
+ - - - SC mutant
- + - - Capped PPT 
mutant
+ + + + ATP
+ + + + GMP-PNP
+ + + + RRL
A
B
Figure 2. XIAP IRES initiation complexes are IRES dependent.
(A) Secondary structure model of the XIAP IRES (54) with the
introduced mutations within the IRES indicated. The UU sequence
of the polypyrimidine tract was mutated to AA in the PPT mutant
(indicated with a rectangle); the initiation codon AUG was replaced
with AAC in the SC mutant (indicated with a circle). (B) Toeprinting
analysis was carried out to determine the ability of PPT, capped PPT
and SC XIAP IRES mutants to form initiation complexes in RRL
pre-treated with GMP-PNP and ATP.
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eluate was then analyzed by TBE agarose gel electrophor-
esis. The presence of 40S and 60S RNA and free XIAP
IRES RNA in the eluate conﬁrmed that the 80S was
indeed formed on XIAP IRES RNA in poly I:C treated
RRL (Figure 4B). Toeprinting analysis of the eluate
further conﬁrmed the presence of 80S initiation complexes
(Figure 4C). In contrast, the 80S initiation complex could
not be isolated in a control reaction (Supplementary
Figure S3A). These data indicate that XIAP IRES 80S
initiation complex was puriﬁed speciﬁcally using XIAP
IRES RNA afﬁnity chromatography.
An eIF5B-dependent mode of XIAP IRES-mediated
translation initiation
We have shown that the XIAP IRES is capable of recruit-
ing ribosomes and forming translation initiation complex
even when eIF2a is inactivated by phosphorylation.
Previous reports identiﬁed a bacterial-like mode of trans-
lation initiation on viral IRES [HCV, (32); CSFV, (31)]
that utilizes eIF5B when eIF2a is inactivated by phos-
phorylation. This prompted us to investigate if eIF5B
could also be used by a cellular IRES when eIF2a is
phosphorylated. Initiation factors eIF2a and/or eIF5B
were thus immuno-inactivated in RRL prior to perform-
ing the toeprinting assay on the XIAP IRES RNA. We
observed that initiation complex formation was partially
inhibited when either eIF2a or eIF5B were immuno-
inactivated; however, XIAP IRES initiation complex for-
mation was completely abrogated when both eIF2a and
eIF5B were immuno-inactivated (Figure 5A).
In order to extend our in vitro data, we wished to verify
the alternative role of eIF2a and eIF5B in translation ini-
tiation on XIAP IRES in cells. HEK293T cells were tran-
siently transfected with siRNA targeting either eIF5B
P-eIF2α
eIF2α
50 min
60 min
0 min
40 min
30 min
10 min
20 min
Poly I:C treatment
Full Length
AUG
17 - 19 NT
from AUG
Full Length
AUG
17 - 19 NT
from AUG
- + + GMP-PNP
+ - - GTP
+ + - poly I:C
T GC 3 2 1 A
+ + - ATP
+ + + XIAP IRES RNA
+ + + RRL
T GC 2 1 A
+ - poly I:C
+ + ATP
+ + GMP-PNP
+ + Capped PPT mutant
+ + RRL
C B
A
Figure 3. eIF2a phosphorylation-independent formation of the XIAP IRES initiation complexes. (A) RRL was treated with poly I:C (to induce
eIF2a phosphorylation) and ATP for the indicated times; western blot analysis was performed to conﬁrm phosphorylation of eIF2a.( B) Toeprinting
assay of XIAP IRES initiation complexes was performed in the presence of GMP-PNP or GTP in RRL pre-treated with poly I:C and ATP. (C) The
ability of the capped PPT mutant to form initiation complexes in poly I:C treated and untreated RRL was determined by toeprinting assay as in (B).
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stantial reduction of eIF5B expression was achieved 72h
following siRNA transfection (Figure 5B, lower panel), at
which point poly I:C transfection for an additional 18h
was used to induce eIF2a phosphorylation. The levels of
endogenous XIAP protein were determined by western
blot analysis (Figure 5B). As anticipated from our
in vitro results, XIAP protein levels remained unchanged
by either eIF2a phosphorylation or reduced eIF5B expres-
sion. However, XIAP protein levels were decreased by
50% when eIF5B expression decreased and eIF2a was
phosphorylated simultaneously (Figure 5B).
We have shown recently that the translation of XIAP is
alternatively regulated by two 50-UTRs: a 323 nucleotide
UTR (shorter) or a 1700 nucleotide UTR (longer). The
longer UTR contains the IRES element and is used
preferentially during stress, whereas translation mediated
by the shorter UTR is cap dependent (11). To directly
measure the effect of eIF2a phosphorylation and eIF5B
reduction on the translation of the endogenous XIAP
IRES-containing mRNA, polysome proﬁling was per-
formed to determine the association of XIAP IRES con-
taining mRNA with translating polysomes. HEK293T
cells were transfected with eIF5B-speciﬁc siRNA and sub-
sequently transfected with poly I:C, and the polysomal
distribution of mRNAs was analyzed by density gradient
centrifugation (Figure 5C). Western blot analysis was per-
formed to verify eIF5B knockdown and phosphorylation
of eIF2a in the lysates prepared for polysome proﬁling
(Supplementary Figure S4A). Treatment of cells with
poly I:C resulted in an attenuation of cap-dependent
translation due to eIF2a phosphorylation, as demonst-
rated by a loss of high molecular weight polysomes and
an increase in the non-polysomal peaks (Figure 5C).
Surprisingly, we did not observe signiﬁcant decrease in
high molecular weight polysomes when eIF5B levels
were reduced by siRNA. Although, eIF5B is known to
play a role in ribosomal subunit joining (33), Pestova
et al. (31) reported that eIF5B is dispensable to form elong-
ation competent 80S initiation complex on CSFV IRES.
This suggests that eIF5B is not essential for ribosomal
subunit joining. The quantitative RT–PCR analysis of
individual fractions showed that the endogenous
IRES-containing XIAP mRNA remains in polysomes
even when eIF2a is phosphorylated (Figure 5D,
Supplementary Figure S4C). In contrast, b-actin and
non-IRES XIAP (shorter-UTR) mRNAs shifted toward
non-polysomes upon eIF2a phosphorylation (Figure 5D,
Supplementary Figure S4C). Similarly, the reduced ex-
pression of eIF5B did not affect the association
of IRES-containing XIAP mRNA with polysomes
(Figure 5D, Supplementary Figure S4C). In contrast, the
IRES-containing XIAP mRNA was shifted toward
non-polysomes from polysomes when eIF5B expression
was reduced and eIF2a was phosphorylated. However,
steady-state levels of XIAP IRES mRNAs were not sig-
niﬁcantly affected by poly I:C transfection, reduced ex-
pression of eIF5B or by combination of both
(Supplementary Figure S4B). These data indicate that
XIAP IRES-dependent translation relies on eIF5B when
eIF2a is phosphorylated. Together, these observations
support a model in which translation initiation mediated
by the XIAP IRES switches from an eIF2-dependent
mode to an eIF5B-dependent mode when the availability
of ternary complex decreases due to eIF2a
phosphorylation.
DISCUSSION
XIAP is a potent IAP that interacts directly with caspases
3, 7 and 9 to block cell death (34). Cell survival during
pathophysiological stress conditions depends on the abun-
dance and activity of XIAP protein, which is determined
at least partially by the expression mediated by its IRES.
Interestingly, several groups reported that the
IRES-mediated translation of XIAP is sustained during
Full length
80S
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from AUG
A C G T
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60S
Eluate
XIAP IRES RNA
Load + Wash
Elution
A
C
B
Figure 4. Isolation of XIAP IRES initiation complexes formed in poly
I:C-treated RRL. RRL was supplemented with puriﬁed 40S and 60S
subunits from HeLa cells and subsequently treated with poly I:C, ATP
and cycloheximide. Initiation complexes were formed on strepto-tagged
XIAP IRES RNA and afﬁnity puriﬁed using streptomycin afﬁnity
chromatography as described by Locker et al. (20). (A) A typical
proﬁle of RNA/initiation complex elution from the dihydro-
streptomycin column. (B) Agarose gel electrophoresis analysis of the
eluate from the streptomycin column. (C) Without further puriﬁcation
5ml of eluate was analyzed by toeprinting assay for XIAP IRES initi-
ation complexes.
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Figure 5. Translation initiation on XIAP IRES RNA switches to an eIF5B-dependent mode when eIF2 is inactivated. (A) A quantity of 5ml of RRL
was incubated with the anti-eIF2a and/or anti-eIF5B antibodies at 4 C overnight. Following the immuno-inactivation of the indicated initiation
factors, the toeprinting assay of the XIAP IRES initiation complex was performed. (B) HEK293T cells were transiently transfected with siRNA
targeting eIF5B or non-targeting control siRNA and poly I:C as indicated. Western blot analysis (upper panel) was performed to verify eIF5B
knockdown and phosphorylation of eIF2a, and the levels of endogenous XIAP protein. XIAP levels are represented as the ratio of XIAP to b-actin
(lower panel; n=4, mean SEM). The actin blot used for XIAP normalization is indicated with an asterisk. (C) Polysome proﬁling of HEK293T
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(continued)pathophysiological stress (8–11,35), despite the fact that
these conditions lead to phosphorylation of eIF2a and a
consequent reduction in the levels of available ternary
complex which is required for translation of both
capped and uncapped mRNAs. Here, we present the
ﬁrst functional characterization of cellular IRES in vitro
and explain the mechanism by which translation initiation
on XIAP IRES occurs during pathophysiological stress
condition when eIF2a is phosphorylated. We show that
XIAP IRES-dependent translation initiation switches to
an eIF5B-dependent mode to avoid attenuation due to
eIF2a phosphorylation.
We have used a toeprinting assay in RRL to show that
the XIAP IRES recruits ribosome in the absence of a m
7G
cap and thus supports bona ﬁde cap-independent transla-
tion. Since the validity of the XIAP IRES has been ques-
tioned in several recent reports (36,37) our data add
unequivocal evidence to support the authenticity of the
XIAP IRES. Previously it was shown that translation of
cellular IRES is enhanced by the presence of poly-A tail in
a cell-free translation system (28). Indeed, this is also true
for the XIAP IRES, as we observed impaired ability of the
IRES to form an initiation complex in the absence of
poly-A-tail. In vitro initiation on the XIAP IRES forms
either a 48S or a 80S initiation complex depending
on available guanine nucleotides. These two types of ini-
tiation complexes were revealed by determining distribu-
tion of ﬂuorescence intensities of the 40S leading edge
toeprints (Figure 1). Toeprinting assays performed in
cycloheximide-treated RRL yielded enhanced intensity of
the 40S leading edge toeprints (Supplementary
Figure S1C, compare lanes 1 and 4). This indicates that
a high proportion of XIAP IRES RNAs harbor an
elongation-competent 80S initiation complex, which can
be inhibited by cycloheximide treatment, and provides
evidence that the initiation complex formed on uncapped
XIAP IRES RNA is indeed translation competent. We
have shown previously that in vivo XIAP IRES activity
is abolished by point mutations within the PPT of XIAP
IRES (24). We have expanded this observation here in an
in vitro toeprinting assay and demonstrate that mutations
within the PPT abolished the ability of uncapped XIAP
IRES to form an initiation complex probably due to al-
teration in the secondary structure and/or IRES
trans-acting factors (ITAFs) binding site. Interestingly,
the formation of the 40S leading edge toeprints was re-
stored by the addition of a 50 m
7G cap to the PPT mutant
IRES RNA, indicating that the recruitment of the
ribosome and the subsequent formation of the initiation
complex is sequence-speciﬁc and requires a functional
IRES (Figure 2).
Published toeprinting analyses performed in RRL using
HCV IRES, capped human b-globin or capped Hsp70
RNAs obtained 40S leading edge toeprints +16 to
+18nt downstream of the AUG (20,21,27,29). Using a
capped human b-globin RNA, we have also observed
40S leading edge toeprints +16 to +18nt downstream of
the AUG (Supplementary Figure S1B). In contrast,
toeprinting analysis of XIAP IRES RNA or the capped
PPT mutant of XIAP IRES identiﬁed 40S leading edge
toeprints +17 to +18nt downstream of the AUG, for
both 48S and 80S initiation complexes. It was suggested
that changes in the structural organization of the 40S
subunit within the initiation complex result in a change
in the distribution of ﬂuorescence intensities of 40S
leading edge toeprints (27,29). Therefore, our data
suggest that the conformation of 40S subunit in either
the 48S or 80S initiation complexes formed on the XIAP
IRES or capped PPT mutant is different from that formed
on HCV IRES, or capped non-IRES RNAs.
Having established a faithful in vitro system to study
XIAP IRES-dependent translation, we sought to dissect
the mechanism that allows the translation of cellular
IRES-containing mRNAs during conditions of cellular
stress, which are typiﬁed by phosphorylated eIF2a.
Several lines of evidence suggest that translation of
IRES-containing mRNAs may continue even in the pres-
ence of phosphorylated eIF2a. For example, the
IRES-mediated translation of VEGF and p120 catenin is
resistant to the global translation attenuation due to
eIF2a phosphorylation in the hypoxic environment of
the inﬂammatory breast tumor (38,39). Similarly,
enhanced translation of XIAP was observed in hypoxic
breast cancer cell lines (40–42) in which the eIF2a
remains phosphorylated due to higher abundance and
activity of PKR (43). In addition, glucose deﬁciency
induces phosphorylation of eIF2a and inhibition of
protein synthesis but the XIAP mRNA can bypass this
translational block (10). Our group has shown previously
that the IRES-containing variant of XIAP mRNA is pref-
erentially translated during serum deprivation which also
leads to eIF2a phosphorylation (11). Here, we conﬁrm
these observation in an in vitro system and show that
XIAP IRES forms an initiation complex in poly I:C
treated RRL where eIF2a is phosphorylated (Figure 3).
Using a RNA afﬁnity chromatography approach we have
isolated 80S initiation complex formed on the XIAP IRES
RNA in poly I:C-treated RRL and show that the 80S
initiation complex can be formed without the participa-
tion of eIF2 (Figure 4). Importantly, translation of the
endogenous XIAP mRNA was not decreased in poly
I:C-transfected HEK293T cells as determined by western
blot analysis and polysome proﬁling (Figure 5). This indi-
cates that the IRES-mediated translation of XIAP is
indeed resistant to the global translation attenuation
imparted by eIF2a phosphorylation. Interestingly, only
Figure 5. Continued
cells transiently transfected with siRNA targeting eIF5B or non-targeting control siRNA and poly I:C as indicated. Non-polysome (translationally
inactive) and polysome (translationally active) fractions are separated by broken vertical lines. Representative proﬁle of three independent experi-
ments is shown. (D) Individual fractions were probed for the presence of b-actin and IRES-containing endogenous XIAP mRNAs by qRT–PCR.
Percent distribution of speciﬁc mRNAs relative to the spiked CAT RNA control across the gradient was determined. The amount (%) of speciﬁc
mRNA present in polysomes relative to non-polysomes quantiﬁes the change in translation efﬁciency (n=3, mean SEM).
Nucleic AcidsResearch, 2012, Vol.40,No. 2 549the 48S but not the 80S initiation complex could be
formed and isolated from RRL treated with GMP-PNP
(Figure 1B, lane 2; Supplementary Figure S3B). Under
these conditions eIF2a is not inactivated by phosphoryl-
ation and therefore our data suggest that XIAP IRES
RNA preferentially utilizes an eIF2a-dependent transla-
tion initiation mechanism under normal conditions when
eIF2 is fully active, whereas translation initiation on XIAP
IRES RNA switches to an alternative, eIF2a-independent
mode when the availability of ternary complex is reduced.
A few eIF2-independent modes of translation initiation
have been proposed recently for the translation of viral
RNAs. eIF2D (44), Ligatin, and MCT-1/DENR (45)
have all been reported to deliver tRNA into the P-site of
ribosome during HCV IRES-mediated translation. An
eIF2-independent mode of translation initiation on
CSFV IRES has been reported in which eIF5B, an eukary-
otic homologue of bacterial IF2, delivers tRNA into the
P-site of the ribosome to form a translation-competent
initiation complex (31). Similar switch from an eukaryotic
to a bacterial-like mode of translation initiation has been
reported for the HCV IRES when eIF2a is inactivated by
phosphorylation (32). The ability of HCV and CSFV
IRES to recruit and place the 40S subunit in the vicinity
of initiation codon in a scanning-independent manner
allows them to utilize an eIF5B dependent mode of trans-
lation initiation (31,32). We report for the ﬁrst time that a
cellular IRES-containing mRNA utilizes a similar, eIF2a-
independent mode of translation. A stable complex
between the puriﬁed ribosome and XIAP IRES RNA
could not be detected by a gel-shift assay performed in
the absence of ITAFs or by a toeprinting assay performed
in the absence of RRL (data not shown). However, the
XIAP IRES initiation complex could be formed in RRL
treated with hippuristanol (a small molecule inhibitor of
eIF4A), indicating that eIF4A-dependent ribosome
scanning is not required and the ribosome is likely
placed in the vicinity of the AUG codon to form an initi-
ation complex (Supplementary Figure S5). These observa-
tions strongly suggest the possibility that an
eIF5B-dependent pathway operates on the XIAP IRES.
Our in vivo data conﬁrm this model, since we ﬁnd that
expression of XIAP protein decreases only when eIF5B
expression is reduced and eIF2a is phosphorylated
(Figure 5). This is in contrast to the cap-dependent trans-
lation of b-actin mRNA, which is decreased when eIF2a
is phosphorylated (Figure 5). Thus we show that like viral
IRES, a cellular IRES can operate in an eIF5B-dependent
manner when the availability of ternary complex de-
creases due to eIF2a phosphorylation. We wished to
extend our observations to other cellular IRES-containing
mRNAs, and therefore assessed the polysomal distri-
bution of mRNAs that encode other regulators of apop-
tosis, namely Bcl-xL, cIAP1, Apaf-1 and p97/DAP5.
Surprisingly, we ﬁnd that translation of these mRNAs is
unable to utilize eIF5B when global translation is
attenuated due to phosphorylation of eIF2a (data not
shown), suggesting that not all cellular IRES operate in
an eIF5B dependent mode.
Chemoresistance of many cancer cell types have been
correlated with overexpression of XIAP (17,46–49). In
fact, XIAP has been validated as a potent therapeutic
target and various anti-XIAP strategies for cancer treat-
ment are currently being tested in clinical trials (50). The
speciﬁcity of these therapeutics for tumor cells is desirable,
since XIAP deﬁciency in non-cancerous cells can lead to
disorders such as X-linked lymphoproliferative disease
(51,52). It is tempting to propose that speciﬁc targeting
of the eIF5B-dependent mode of XIAP IRES-mediated
translation may allow a reduction of XIAP levels only
in cancer cells which express high levels of eIF2 (53).
Therefore, it is crucial to understand the process of
IRES-mediated translation initiation of XIAP during
pathophysiological stress. The mechanism proposed in
this report is the ﬁrst step toward understanding the
process of ribosome recruitment and initiation complex
formation on XIAP IRES during pathophysiological
stress.
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Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Dr. Stephen Baird for assistance with LI-COR’s
4200 IR2 sequence analyzer and e-Seq software, Fahad
Shamim for technical assistance, Faraz Farooq and
members of the laboratory for their insightful discussion
of the project. We are grateful to Dr. Peter Lukavsky for
the gift of strepto-tagged HCV IRES construct, and to Dr.
Jerry Pelletier for the gift of hippuristanol. MH is the
CHEO Volunteer Association Endowed Scholar.
FUNDING
Canadian Institutes of Health Research (operating grant,
MOP-89737). Funding for open access charge: CIHR
MOP-89737.
REFERENCES
1. Holcik,M. and Sonenberg,N. (2005) Translational control in stress
and apoptosis. Nat. Rev. Mol. Cell. Biol., 6, 318–327.
2. Komar,A.A. and Hatzoglou,M. (2011) Cellular IRES-mediated
translation: the war of ITAFs in pathophysiological states.
Cell Cycle, 10, 229–240.
3. Silvera,D., Formenti,S.C. and Schneider,R.J. (2010) Translational
control in cancer. Nat. Rev. Cancer, 10, 254–266.
4. Braunstein,S., Karpisheva,K., Pola,C., Goldberg,J., Hochman,T.,
Yee,H., Cangiarella,J., Arju,R., Formenti,S.C. and Schneider,R.J.
(2007) A hypoxia-controlled cap-dependent to cap-independent
translation switch in breast cancer. Mol. Cell, 28, 501–512.
5. Gebauer,F. and Hentze,M.W. (2004) Molecular mechanisms of
translational control. Nat. Rev. Mol. Cell. Biol., 5, 827–835.
6. Ron,D. and Harding,H.P. (2007) eIF2a phosphorylation in
cellular stress responses and disease. In Mathews,M.B.,
Sonenberg,N. and Hershey,J.W.B. (eds), Translational Control in
Biology and Medicine. Cold Spring Harbor Laboratory Press,
New York, pp. 345–368.
7. Warnakulasuriyarachchi,D., Cerquozzi,S., Cheung,H.H. and
Holcik,M. (2004) Translational induction of the inhibitor of
apoptosis protein HIAP2 during endoplasmic reticulum stress
attenuates cell death and is mediated via an inducible internal
ribosome entry site element. J. Biol. Chem., 279, 17148–17157.
550 Nucleic Acids Research, 2012,Vol. 40,No. 28. Gu,L., Zhu,N., Zhang,H., Durden,D.L., Feng,Y. and Zhou,M.
(2009) Regulation of XIAP translation and induction by MDM2
following irradiation. Cancer Cell, 15, 363–375.
9. Holcik,M., Yeh,C., Korneluk,R.G. and Chow,T. (2000)
Translational upregulation of X-linked inhibitor of apoptosis
(XIAP) increases resistance to radiation induced cell death.
Oncogene, 19, 4174–4177.
10. Muaddi,H., Majumder,M., Peidis,P., Papadakis,A.I., Holcik,M.,
Scheuner,D., Kaufman,R.J., Hatzoglou,M. and Koromilas,A.E.
(2010) Phosphorylation of eIF2alpha at serine 51 is an important
determinant of cell survival and adaptation to glucose deﬁciency.
Mol. Biol. Cell, 21, 3220–3231.
11. Riley,A., Jordan,L.E. and Holcik,M. (2010) Distinct 50 UTRs
regulate XIAP expression under normal growth conditions and
during cellular stress. Nucleic Acids Res., 38, 4665–4674.
12. Liston,P., Fong,W.G. and Korneluk,R.G. (2003) The inhibitors
of apoptosis: there is more to life than Bcl2. Oncogene, 22,
8568–8580.
13. Gyrd-Hansen,M. and Meier,P. (2010) IAPs: from caspase
inhibitors to modulators of NF-kappaB, inﬂammation and cancer.
Nat. Rev. Cancer, 10, 561–574.
14. Carter,B.Z., Mak,D.H., Morris,S.J., Borthakur,G., Estey,E.,
Byrd,A.L., Konopleva,M., Kantarjian,H. and Andreeff,M. (2011)
XIAP antisense oligonucleotide (AEG35156) achieves target
knockdown and induces apoptosis preferentially in CD34+38-
cells in a phase 1/2 study of patients with relapsed/refractory
AML. Apoptosis, 16, 67–74.
15. Dean,E., Jodrell,D., Connolly,K., Danson,S., Jolivet,J., Durkin,J.,
Morris,S., Jowle,D., Ward,T., Cummings,J. et al. (2009) Phase I
trial of AEG35156 administered as a 7-day and 3-day continuous
intravenous infusion in patients with advanced refractory cancer.
J. Clin. Oncol., 27, 1660–1666.
16. Schimmer,A.D., Estey,E.H., Borthakur,G., Carter,B.Z.,
Schiller,G.J., Tallman,M.S., Altman,J.K., Karp,J.E., Kassis,J.,
Hedley,D.W. et al. (2009) Phase I/II trial of AEG35156 X-linked
inhibitor of apoptosis protein antisense oligonucleotide combined
with idarubicin and cytarabine in patients with relapsed or
primary refractory acute myeloid leukemia. J. Clin. Oncol., 27,
4741–4746.
17. Tamm,I., Kornblau,S.M., Segall,H., Krajewski,S., Welsh,K.,
Kitada,S., Scudiero,D.A., Tudor,G., Qui,Y.H., Monks,A. et al.
(2000) Expression and prognostic signiﬁcance of IAP-family genes
in human cancers and myeloid leukemias. Clin. Cancer Res., 6,
1796–1803.
18. Yamagiwa,Y., Marienfeld,C., Meng,F., Holcik,M. and Patel,T.
(2004) Translational regulation of X-linked inhibitor of apoptosis
protein by interleukin-6: a novel mechanism of tumor cell
survival. Cancer Res., 64, 1293–1298.
19. Yoon,A., Peng,G., Brandenburger,Y., Zollo,O., Xu,W., Rego,E.
and Ruggero,D. (2006) Impaired control of IRES-mediated
translation in X-linked dyskeratosis congenita. Science, 312,
902–906.
20. Locker,N., Easton,L.E. and Lukavsky,P.J. (2006) Afﬁnity
puriﬁcation of eukaryotic 48S initiation complexes. RNA, 12,
683–690.
21. Locker,N. and Lukavsky,P.J. (2007) A practical approach to
isolate 48S complexes: afﬁnity puriﬁcation and analyses.
Methods Enzymol., 429, 83–104.
22. Lukavsky,P.J. and Puglisi,J.D. (2004) Large-scale preparation and
puriﬁcation of polyacrylamide-free RNA oligonucleotides. RNA,
10, 889–893.
23. Li,J., Feng,Q., Kim,J.M., Schneiderman,D., Liston,P., Li,M.,
Vanderhyden,B., Faught,W., Fung,M.F., Senterman,M. et al.
(2001) Human ovarian cancer and cisplatin resistance: possible
role of inhibitor of apoptosis proteins. Endocrinology, 142,
370–380.
24. Holcik,M., Lefebvre,C., Yeh,C., Chow,T. and Korneluk,R.G.
(1999) A new internal-ribosome-entry-site motif potentiates
XIAP-mediated cytoprotection. Nat. Cell. Biol., 1, 190–192.
25. Anthony,D.D. and Merrick,W.C. (1992) Analysis of 40 S and 80
S complexes with mRNA as measured by sucrose density
gradients and primer extension inhibition. J. Biol. Chem., 267,
1554–1562.
26. Hartz,D., McPheeters,D.S., Traut,R. and Gold,L. (1988)
Extension inhibition analysis of translation initiation complexes.
Methods Enzymol., 164, 419–425.
27. Shirokikh,N.E., Alkalaeva,E.Z., Vassilenko,K.S., Afonina,Z.A.,
Alekhina,O.M., Kisselev,L.L. and Spirin,A.S. (2010) Quantitative
analysis of ribosome-mRNA complexes at different translation
stages. Nucleic Acids Res., 38, e15.
28. Thoma,C., Bergamini,G., Galy,B., Hundsdoerfer,P. and
Hentze,M.W. (2004) Enhancement of IRES-mediated translation
of the c-myc and BiP mRNAs by the poly(A) tail is independent
of intact eIF4G and PABP. Mol. Cell, 15, 925–935.
29. Dmitriev,S.E., Pisarev,A.V., Rubtsova,M.P., Dunaevsky,Y.E. and
Shatsky,I.N. (2003) Conversion of 48S translation preinitiation
complexes into 80S initiation complexes as revealed by
toeprinting. FEBS Lett., 533, 99–104.
30. Price,N.T., Welsh,G.I. and Proud,C.G. (1991) Phosphorylation of
only serine-51 in protein synthesis initiation factor-2 is associated
with inhibition of peptide-chain initiation in reticulocyte lysates.
Biochem. Biophys. Res. Commun., 176, 993–999.
31. Pestova,T.V., de Breyne,S., Pisarev,A.V., Abaeva,I.S. and
Hellen,C.U. (2008) eIF2-dependent and eIF2-independent modes
of initiation on the CSFV IRES: a common role of domain II.
EMBO J., 27, 1060–1072.
32. Terenin,I.M., Dmitriev,S.E., Andreev,D.E. and Shatsky,I.N.
(2008) Eukaryotic translation initiation machinery can operate in
a bacterial-like mode without eIF2. Nat. Struct. Mol. Biol., 15,
836–841.
33. Fringer,J.M., Acker,M.G., Fekete,C.A., Lorsch,J.R. and
Dever,T.E. (2007) Coupled release of eukaryotic translation
initiation factors 5B and 1A from 80S ribosomes following
subunit joining. Mol. Cell. Biol., 27, 2384–2397.
34. Holcik,M. and Korneluk,R.G. (2001) XIAP, the guardian angel.
Nat. Rev. Mol. Cell. Biol., 2, 550–556.
35. Bevilacqua,E., Wang,X., Majumder,M., Gaccioli,F., Yuan,C.L.,
Wang,C., Zhu,X., Jordan,L.E., Scheuner,D., Kaufman,R.J. et al.
(2010) eIF2alpha phosphorylation tips the balance to apoptosis
during osmotic stress. J. Biol. Chem., 285, 17098–17111.
36. Baranick,B.T., Lemp,N.A., Nagashima,J., Hiraoka,K.,
Kasahara,N. and Logg,C.R. (2008) Splicing mediates the
activity of four putative cellular internal ribosome entry sites.
Proc. Natl Acad. Sci. USA, 105, 4733–4738.
37. Saffran,H.A. and Smiley,J.R. (2009) The XIAP IRES activates 30
cistron expression by inducing production of monocistronic
mRNA in the betagal/CAT bicistronic reporter system. RNA, 15,
1980–1985.
38. Silvera,D., Arju,R., Darvishian,F., Levine,P.H., Zolfaghari,L.,
Goldberg,J., Hochman,T., Formenti,S.C. and Schneider,R.J.
(2009) Essential role for eIF4GI overexpression in the
pathogenesis of inﬂammatory breast cancer. Nat. Cell. Biol., 11,
903–908.
39. Silvera,D. and Schneider,R.J. (2009) Inﬂammatory breast cancer
cells are constitutively adapted to hypoxia. Cell Cycle, 8,
3091–3096.
40. Aird,K.M., Ding,X., Baras,A., Wei,J., Morse,M.A., Clay,T.,
Lyerly,H.K. and Devi,G.R. (2008) Trastuzumab signaling in
ErbB2-overexpressing inﬂammatory breast cancer correlates
with X-linked inhibitor of apoptosis protein expression.
Mol. Cancer Ther., 7, 38–47.
41. Aird,K.M., Ghanayem,R.B., Peplinski,S., Lyerly,H.K. and
Devi,G.R. (2010) X-linked inhibitor of apoptosis protein
inhibits apoptosis in inﬂammatory breast cancer cells with
acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.
Mol. Cancer Ther., 9, 1432–1442.
42. Shi,Z., Liang,Y.J., Chen,Z.S., Wang,X.H., Ding,Y., Chen,L.M.
and Fu,L.W. (2007) Overexpression of Survivin and XIAP in
MDR cancer cells unrelated to P-glycoprotein. Oncol Rep., 17,
969–976.
43. Kim,S.H., Forman,A.P., Mathews,M.B. and Gunnery,S. (2000)
Human breast cancer cells contain elevated levels and activity of
the protein kinase, PKR. Oncogene, 19, 3086–3094.
44. Dmitriev,S.E., Terenin,I.M., Andreev,D.E., Ivanov,P.A.,
Dunaevsky,J.E., Merrick,W.C. and Shatsky,I.N. (2010)
GTP-independent tRNA delivery to the ribosomal P-site by a
Nucleic AcidsResearch, 2012, Vol.40,No. 2 551novel eukaryotic translation factor. J. Biol. Chem., 285,
26779–26787.
45. Skabkin,M.A., Skabkina,O.V., Dhote,V., Komar,A.A.,
Hellen,C.U. and Pestova,T.V. (2010) Activities of ligatin and
MCT-1/DENR in eukaryotic translation initiation and ribosomal
recycling. Genes Dev., 24, 1787–1801.
46. Carter,B.Z., Gronda,M., Wang,Z., Welsh,K., Pinilla,C.,
Andreeff,M., Schober,W.D., Nefzi,A., Pond,G.R., Mawji,I.A.
et al. (2005) Small-molecule XIAP inhibitors derepress
downstream effector caspases and induce apoptosis of acute
myeloid leukemia cells. Blood, 105, 4043–4050.
47. LaCasse,E.C., Mahoney,D.J., Cheung,H.H., Plenchette,S., Baird,S.
and Korneluk,R.G. (2008) IAP-targeted therapies for cancer.
Oncogene, 27, 6252–6275.
48. Pardo,O.E., Lesay,A., Arcaro,A., Lopes,R., Ng,B.L., Warne,P.H.,
McNeish,I.A., Tetley,T.D., Lemoine,N.R., Mehmet,H. et al.
(2003) Fibroblast growth factor 2-mediated translational control
of IAPs blocks mitochondrial release of Smac/DIABLO and
apoptosis in small cell lung cancer cells. Mol. Cell. Biol., 23,
7600–7610.
49. Schimmer,A.D., Welsh,K., Pinilla,C., Wang,Z., Krajewska,M.,
Bonneau,M.J., Pedersen,I.M., Kitada,S., Scott,F.L.,
Bailly-Maitre,B. et al. (2004) Small-molecule antagonists of
apoptosis suppressor XIAP exhibit broad antitumor activity.
Cancer Cell, 5, 25–35.
50. Flygare,J.A. and Fairbrother,W.J. (2010) Small-molecule pan-IAP
antagonists: a patent review. Expert. Opin. Ther. Pat., 20,
251–267.
51. Marsh,R.A., Madden,L., Kitchen,B.J., Mody,R., McClimon,B.,
Jordan,M.B., Bleesing,J.J., Zhang,K. and Filipovich,A.H. (2010)
XIAP deﬁciency: a unique primary immunodeﬁciency best
classiﬁed as X-linked familial hemophagocytic lymphohistiocytosis
and not as X-linked lymphoproliferative disease. Blood, 116,
1079–1082.
52. Rigaud,S., Fondaneche,M.C., Lambert,N., Pasquier,B., Mateo,V.,
Soulas,P., Galicier,L., Le Deist,F., Rieux-Laucat,F., Revy,P. et al.
(2006) XIAP deﬁciency in humans causes an X-linked
lymphoproliferative syndrome. Nature, 444, 110–114.
53. Schneider,R.J. and Sonenberg,N. (2007) Translational control in
cancer development and progression. In Mathews,M.B.,
Sonenberg,N. and Hershey,J.W.B. (eds), Translational Control in
Biology and Medicine. Cold Spring Harbor Laboratory Press,
New York, pp. 401–431.
54. Baird,S.D., Lewis,S.M., Turcotte,M. and Holcik,M. (2007) A
search for structurally similar cellular internal ribosome entry
sites. Nucleic Acids Res., 35, 4664–4677.
552 Nucleic Acids Research, 2012,Vol. 40,No. 2